SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-23-063050
Filing Date
2023-11-13
Accepted
2023-11-13 16:36:37
Documents
5
Period of Report
2023-11-13

Document Format Files

Seq Description Document Type Size
1 6-K achl-2023_-_6-k_q3_2023.htm 6-K 40225
2 EX-99.1 achl-ex99_1.htm EX-99.1 260107
3 EX-99.2 achl-ex99_2.htm EX-99.2 1241723
4 EX-99.3 achl-ex99_3.htm EX-99.3 395399
5 GRAPHIC img60901631_0.jpg GRAPHIC 16721
  Complete submission text file 0000950170-23-063050.txt   1961718
Mailing Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW 44 (0)20 8154 4600
Achilles Therapeutics plc (Filer) CIK: 0001830749 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40299 | Film No.: 231399478
SIC: 2836 Biological Products, (No Diagnostic Substances)